Thermo Fisher and LabShares support biotech startups with equipment May 20, 2022 -- Thermo Fisher Scientific and LabShares Newton have agreed to collaborate in providing resources to early-stage life science companies seeking to grow. The partners intend to equip biotech startups with the instruments, lab equipment, and inputs and consumables needed to develop novel therapies.Read More
Piramal Pharma Solutions launches API plant for operation in Canada May 20, 2022 -- Piramal Pharma Solutions has brought its active pharmaceutical ingredient (API) production plant into operation, following the completion of its first clinical and commercial scale projects. The new facility, located in Aurora, Ontario, occupies over 10,000 square feet dedicated to manufacturing processes. The plant is part of a CAD $30 million investment by Piramal Pharma Solutions to enhance its API production capabilities.Read More
Precision BioSciences highlights hepatitis B virus drug research May 19, 2022 -- Precision BioSciences is highlighting new research showing that its gene editing drug candidate targeting the hepatitis B virus (HBV) achieved an 85% reduction in covalently closed circular DNA and a 77% reduction in hepatitis B surface antigen in HBV-infected primary human hepatocytes.Read More
Forge Biologics assembles scientific and manufacturing advisory board May 18, 2022 -- Forge Biologics has created its new Scientific and Manufacturing Advisory Board filled with leaders in the field of gene therapy development and manufacturing. This independent panel represents Forge’s commitment to enhancing its gene therapy offerings through insights from experts in the field.Read More
Vida rolls out analysis services for clinical trials May 17, 2022 -- Lung imaging software developer Vida Diagnostics has introduced a suite of retrospective data analysis services for sponsors of clinical trials at this week's American Thoracic Society conference in San Francisco.Read More
Precision BioSciences presents preclinical data for gene editing therapies May 17, 2022 -- Precision BioSciences is scheduled to display preclinical data for its Arcus-based gene editing studies at the American Society of Gene & Cell Therapy’s annual meeting in Washington, DC. The showcase will include two oral presentations and two posters highlighting gene editing study results.Read More
Emmes releases standalone cloud software product, Advantage eClinical May 13, 2022 -- Emmes will unveil the third generation of its Advantage eClinical software at the Society for Clinical Trials annual meeting in San Diego. This newly updated program functions as a standalone cloud software product, with improved utility and insights for clinical trial sponsors.Read More
Ultivue enters several partnerships for AI-powered phenomics solutions May 13, 2022 -- Ultivue has entered into multiple partnerships to expand on the use of artificial intelligence (AI) to provide high quality analysis of clinical trial data. Specifically, the collaborations will utilize AI technology to empower the analysis of multiplex immunofluorescence imaging and spatial phenomics.Read More